CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
iThermonitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02410252
NCT02410252N/ACompleted
CompareCT.gov

Use Feasibility of the iThermonitor in Pediatric Patients on Myelosuppresive Therapies for Acute Leukemia and Other Childhood Cancers

Massachusetts General Hospital·interventional·Posted Apr 7, 2015·Updated Oct 22, 2020

In Brief

A clinical study evaluating iThermonitor for Acute Lymphocytic Leukemia and 2 related conditions. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This is a pilot study to evaluate the use feasibility of the iThermonitor, a continuous temperature monitoring device, as a clinical support and patient self-management tool in the management of pediatrics patients on myelosuppressive therapies for acute leukemia and other childhood cancers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma
CountriesUnited States
CollaboratorsDana-Farber Cancer Institute

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 7, 2015
Enrollment StartMay 1, 2015
Primary CompletionJul 1, 2017
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.2 years ago

Interventions

iThermonitordevice

The device is a continuous temperature monitoring tool for home monitoring of temperature. Participants are asked to use this device for two weeks.